DJIA 18,135.72 38.82 0.21%
NASDAQ 4,982.81 15.67 0.32%
S&P 500 2,101.04 2.51 0.12%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

14.08 0.02 (0.11%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SRPT $14.08 0.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.13
Previous Close $14.06
Daily Range $13.85 - $14.39
52-Week Range $11.33 - $40.00
Market Cap $581.5M
P/E Ratio -5.00
Dividend (Yield) $0.00 (0.0%)
Volume 531,072
Average Daily Volume 812,362
Current FY EPS -$3.88




Drug Makers

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website:

News & Commentary

Sarepta Therapeutics Inc.'s Price Target Was Slashed By 27% -- Time to Panic?

It's been a rough 12 months for Sarepta Therapeutics, and it got even rougher on Monday following a substantial price target cut from a Wall Street firm. Find out whether this price cut is justified and what investors should consider doing next.

Insider Trading Alert - SRPT, SNA And TUP Traded By Insiders

Did Researchers Just Discover a Functional Cure for Duchenne Muscular Dystrophy?

Duchenne muscular dystrophy has no cure, and it often kills its victims by their mid-20s. However, a new international study lends hope that a functional cure to this disease could be in the offing.

Sarepta Therapeutics (SRPT) Q4 2014 Results - Earnings Call Webcast

Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog

Will BioMarin (BMRN) Beat Estimates this Earnings Season? - Analyst Blog

Will Exelixis (EXEL) Miss Estimates this Earnings Season? - Analyst Blog

Not Too Late to Ride on Q4 Earnings: 3 Biotech Picks - Earnings ESP

Why One Analyst Sees Over 50% Upside in Sarepta

Bank Of America Upgrades Sarepta Therapeutics On 'Increased Conviction' Of Drug Approval

See More SRPT News...

SRPT's Top Competitors

SRPT $14.08 (0.11%)
Current stock: SRPT
AMGN $159.60 (0.26%)
Current stock: AMGN
GILD $103.42 (0.34%)
Current stock: GILD
BIIB $425.61 (2.77%)
Current stock: BIIB